000 01393 a2200409 4500
005 20250513102826.0
264 0 _c19970109
008 199701s 0 0 eng d
022 _a0918-6158
024 7 _a10.1248/bpb.19.1103
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHashimoto, Y
245 0 0 _aEffect of CYP2C polymorphisms on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
_h[electronic resource]
260 _bBiological & pharmaceutical bulletin
_cAug 1996
300 _a1103-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnticonvulsants
_xpharmacokinetics
650 0 4 _aAryl Hydrocarbon Hydroxylases
650 0 4 _aCytochrome P-450 CYP2C9
650 0 4 _aCytochrome P-450 Enzyme System
_xgenetics
650 0 4 _aEpilepsy
_xmetabolism
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aIsoenzymes
_xgenetics
650 0 4 _aPhenytoin
_xpharmacokinetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aSteroid 16-alpha-Hydroxylase
650 0 4 _aSteroid Hydroxylases
_xgenetics
700 1 _aOtsuki, Y
700 1 _aOdani, A
700 1 _aTakano, M
700 1 _aHattori, H
700 1 _aFurusho, K
700 1 _aIui, K
773 0 _tBiological & pharmaceutical bulletin
_gvol. 19
_gno. 8
_gp. 1103-5
856 4 0 _uhttps://doi.org/10.1248/bpb.19.1103
_zAvailable from publisher's website
999 _c8867520
_d8867520